| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| Market Size (2025) | USD 1.38 Billion |
| Market Size (2030) | USD 1.87 Billion |
| CAGR (2025 - 2030) | 6.20 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
China Self-Monitoring Blood Glucose Devices Market Analysis
The China Self-Monitoring Blood Glucose Devices Market size is estimated at USD 1.38 billion in 2025, and is expected to reach USD 1.87 billion by 2030, at a CAGR of 6.2% during the forecast period (2025-2030).
Blood Glucose Monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood Glucose Monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
As a long-term strategy, China is extending efforts at health promotion, detection, and control of diabetes with academic medical centers (AMCs) and hospitals with effective primary care. AMCs are usually overcrowded with patients with simple conditions, while the primary care system is under-equipped with basic medical infrastructure and an under-qualified workforce. The State Council has encouraged health system integration by promoting a hierarchical medical system, a policy that attempts to attract more patients to primary health centers before going to AMCs.
Innovative technologies such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data such as insulin doses, meals/snacks, and physical activity, can further support self-management while decreasing disease burden and benefitting overall diabetes care. Integration of Blood Glucose Monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.
China Self-Monitoring Blood Glucose Devices Market Trends
Rising Diabetes Prevalence in China
The diabetes population in China is expected to grow by about 1.05% over the forecast period.
According to IDF Diabetes Atlas, an estimated 141 million adults were living with diabetes in China which is a rise of 20% over the past two years. It has the highest number of deaths from diabetes in the Western Pacific region, at approximately 1.4 million, and the second-highest diabetes-related health expenditure in the world. More than half of adults currently living with diabetes in China are undiagnosed.
China has the world's largest population of people with diabetes which continues to grow with the country's rapid urbanization. Chinese Ministry of Health has established a network of National Demonstration Areas to develop pilot projects for health promotion, detection, and control of chronic diseases. Various local government departments with country officials are responsible for overall coordination. Primary care providers promote education and self-management of health conditions through appropriate dietary changes, control of tobacco use, and physical activity which are beneficial for diabetes control.
Self-monitoring is a commitment that many diabetic patients follow for managing their condition. The blood glucose levels help the patients and doctors modify their diet, lifestyle, insulin therapy, and medications to help their blood sugar return to normal. With newer innovations in medical technology, glucometers these days have highly sensitive strips and sensors that can detect every component of blood accurately close to lab results.
Therefore, owing to the increasing diabetes prevalence the studied market is anticipated to witness growth over the analysis period.
Understand The Key Trends Shaping This Market
Download PDF
The Test Strips Segment holds the highest market share in the current year
The Test Strips Segment holds the highest market share of about 73.6% in the current year.
Blood glucose test strips are small disposable strips and are a key component of blood glucose testing. When blood is placed onto the test strip, it reacts with a chemical called glucose oxidase producing gluconic acid from the glucose in the blood. At the other end of the test strip, the meter transfers a current to the test strip. The test strip has electric terminals which allow the meter to measure the current between the terminals. The current between the terminals changes depending on the level of gluconic acid that has been produced. The blood glucose meter then uses an algorithm to work out the blood glucose level based on the difference in current.
The growth in market share of test strips is expected to be higher than that of glucose meters, because of the difference in use-case frequency. The Glucometer is a one-time purchase, however, test strips, on the other hand, are a continuous investment as a test strip needs to be disposed of after one use, causing a recurrent cost impact. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame.
The Healthy China 2030 Plan, approved by the State Council and the Party's Central Committee puts diabetes, along with cancer, hypertension, and cardiovascular diseases in the four major non-communicable diseases with a goal to 'control the prevalence and reduce the probability of early death.' The central government launched a 2017-2025 plan to control non-communicable diseases, which includes increasing the regular monitoring and self-management rate for diabetes patients from 50% to 70% by 2025. Such factors are expected to boost market growth.
Get Analysis on Important Geographic Markets
Download PDF
China Self-Monitoring Blood Glucose Devices Industry Overview
The China Self-Monitoring Blood Glucose Devices Market is fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, Roche, and Ascensia, etc. occupy a major share.
China Self-Monitoring Blood Glucose Devices Market Leaders
-
Roche Diabetes Care
-
Abbott Diabetes Care
-
LifeScan
-
Arkray
-
Sinocare
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
China Self-Monitoring Blood Glucose Devices Market News
- December, 2023: Sinocare Inc. set up offline after-sales service outlets, to explore new thinking of preventing and controlling chronic diseases in China. In addition to offline free detection and maintenance services provided to the users with Sinocare Blood Glucose Meter, as well as chronic disease detection for the blood glucose meter users and the masses nearby on the scene, it will also carry out patient education activities regularly, to improve the management awareness of surrounding residents in chronic disease.
- November, 2022: Roche featured two new glucose meter products, ACCU-CHEK Instant Glucometer and ACCU-CHEK Guide Me Glucometer, and a new digital diabetes management platform at the China International Import Expo to highlight integrated solutions from Roche Pharmaceuticals and Roche Diagnostics. The two glucometers exhibited by Roche Diagnostics are both newly launched in 2022 in China, which can measure blood glucose in a user-friendly way, with measurement accuracy.
China Self-Monitoring Blood Glucose Devices Industry Segmentation
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves, using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The China Self-Monitoring Blood Glucose Devices Market is segmented into Components. The report offers the value (in USD) and volume (in Units) for the above segments.
| Component | Glucometer Devices |
| Test Strips | |
| Lancets |
Need A Different Region or Segment?
Customize Now
China Self-Monitoring Blood Glucose Devices Market Research Faqs
How big is the China Self-Monitoring Blood Glucose Devices Market?
The China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.38 billion in 2025 and grow at a CAGR of 6.20% to reach USD 1.87 billion by 2030.
What is the current China Self-Monitoring Blood Glucose Devices Market size?
In 2025, the China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.38 billion.
Who are the key players in China Self-Monitoring Blood Glucose Devices Market?
Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Arkray and Sinocare are the major companies operating in the China Self-Monitoring Blood Glucose Devices Market.
What years does this China Self-Monitoring Blood Glucose Devices Market cover, and what was the market size in 2024?
In 2024, the China Self-Monitoring Blood Glucose Devices Market size was estimated at USD 1.29 billion. The report covers the China Self-Monitoring Blood Glucose Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Self-Monitoring Blood Glucose Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
China Self-Monitoring Blood Glucose Devices Industry Report
Statistics for the 2025 China Self-Monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Self-Monitoring Blood Glucose Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
